Two Distinct Categories of Focal Deletions in Cancer Genomes. e66264

One of the key questions about genomic alterations in cancer is whether they are functional in the sense of contributing to the selective advantage of tumor cells. The frequency with which an alteration occurs might reflect its ability to increase cancer cell growth, or alternatively, enhanced insta...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2013-06, Vol.8 (6)
Hauptverfasser: Rajaram, Megha, Zhang, Jianping, Wang, Tim, Li, Jinyu, Kuscu, Cem, Qi, Huan, Kato, Mamoru, Grubor, Vladimir, Weil, Robert J, Helland, Aslaug
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 6
container_start_page
container_title PloS one
container_volume 8
creator Rajaram, Megha
Zhang, Jianping
Wang, Tim
Li, Jinyu
Kuscu, Cem
Qi, Huan
Kato, Mamoru
Grubor, Vladimir
Weil, Robert J
Helland, Aslaug
description One of the key questions about genomic alterations in cancer is whether they are functional in the sense of contributing to the selective advantage of tumor cells. The frequency with which an alteration occurs might reflect its ability to increase cancer cell growth, or alternatively, enhanced instability of a locus may increase the frequency with which it is found to be aberrant in tumors, regardless of oncogenic impact. Here we've addressed this on a genome-wide scale for cancer-associated focal deletions, which are known to pinpoint both tumor suppressor genes (tumor suppressors) and unstable loci. Based on DNA copy number analysis of over one-thousand human cancers representing ten different tumor types, we observed five loci with focal deletion frequencies above 5%, including the A2BP1 gene at 16p13.3 and the MACROD2 gene at 20p12.1. However, neither RNA expression nor functional studies support a tumor suppressor role for either gene. Further analyses suggest instead that these are sites of increased genomic instability and that they resemble common fragile sites (CFS). Genome-wide analysis revealed properties of CFS-like recurrent deletions that distinguish them from deletions affecting tumor suppressor genes, including their isolation at specific loci away from other genomic deletion sites, a considerably smaller deletion size, and dispersal throughout the affected locus rather than assembly at a common site of overlap. Additionally, CFS-like deletions have less impact on gene expression and are enriched in cell lines compared to primary tumors. We show that loci affected by CFS-like deletions are often distinct from known common fragile sites. Indeed, we find that each tumor tissue type has its own spectrum of CFS-like deletions, and that colon cancers have many more CFS-like deletions than other tumor types. We present simple rules that can pinpoint focal deletions that are not CFS-like and more likely to affect functional tumor suppressors.
doi_str_mv 10.1371/journal.pone.0066264
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_1412504939</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1412504939</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_14125049393</originalsourceid><addsrcrecordid>eNqVzE0OgjAQQOHGxET8uYGLLt2ILYUqaxA9AHvSkMGUlA4yJV5fY7yAq7f58hjbSxFLdZanHufJGxeP6CEWQutEpwsWyVwlR50ItWJrol6ITF20jlhZv5CXloL1beCFCfDAyQJx7HiFrXG8BAfBoidu_Qf4FiZ-A48DUMzh-9-yZWccwe7XDTtU17q4H8cJnzNQaAZLLThnPOBMjUxlkok0V7n6g74BLzJEPQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1412504939</pqid></control><display><type>article</type><title>Two Distinct Categories of Focal Deletions in Cancer Genomes. e66264</title><source>Public Library of Science (PLoS) Journals Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Rajaram, Megha ; Zhang, Jianping ; Wang, Tim ; Li, Jinyu ; Kuscu, Cem ; Qi, Huan ; Kato, Mamoru ; Grubor, Vladimir ; Weil, Robert J ; Helland, Aslaug</creator><creatorcontrib>Rajaram, Megha ; Zhang, Jianping ; Wang, Tim ; Li, Jinyu ; Kuscu, Cem ; Qi, Huan ; Kato, Mamoru ; Grubor, Vladimir ; Weil, Robert J ; Helland, Aslaug</creatorcontrib><description>One of the key questions about genomic alterations in cancer is whether they are functional in the sense of contributing to the selective advantage of tumor cells. The frequency with which an alteration occurs might reflect its ability to increase cancer cell growth, or alternatively, enhanced instability of a locus may increase the frequency with which it is found to be aberrant in tumors, regardless of oncogenic impact. Here we've addressed this on a genome-wide scale for cancer-associated focal deletions, which are known to pinpoint both tumor suppressor genes (tumor suppressors) and unstable loci. Based on DNA copy number analysis of over one-thousand human cancers representing ten different tumor types, we observed five loci with focal deletion frequencies above 5%, including the A2BP1 gene at 16p13.3 and the MACROD2 gene at 20p12.1. However, neither RNA expression nor functional studies support a tumor suppressor role for either gene. Further analyses suggest instead that these are sites of increased genomic instability and that they resemble common fragile sites (CFS). Genome-wide analysis revealed properties of CFS-like recurrent deletions that distinguish them from deletions affecting tumor suppressor genes, including their isolation at specific loci away from other genomic deletion sites, a considerably smaller deletion size, and dispersal throughout the affected locus rather than assembly at a common site of overlap. Additionally, CFS-like deletions have less impact on gene expression and are enriched in cell lines compared to primary tumors. We show that loci affected by CFS-like deletions are often distinct from known common fragile sites. Indeed, we find that each tumor tissue type has its own spectrum of CFS-like deletions, and that colon cancers have many more CFS-like deletions than other tumor types. We present simple rules that can pinpoint focal deletions that are not CFS-like and more likely to affect functional tumor suppressors.</description><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0066264</identifier><language>eng</language><subject>Cancer</subject><ispartof>PloS one, 2013-06, Vol.8 (6)</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids></links><search><creatorcontrib>Rajaram, Megha</creatorcontrib><creatorcontrib>Zhang, Jianping</creatorcontrib><creatorcontrib>Wang, Tim</creatorcontrib><creatorcontrib>Li, Jinyu</creatorcontrib><creatorcontrib>Kuscu, Cem</creatorcontrib><creatorcontrib>Qi, Huan</creatorcontrib><creatorcontrib>Kato, Mamoru</creatorcontrib><creatorcontrib>Grubor, Vladimir</creatorcontrib><creatorcontrib>Weil, Robert J</creatorcontrib><creatorcontrib>Helland, Aslaug</creatorcontrib><title>Two Distinct Categories of Focal Deletions in Cancer Genomes. e66264</title><title>PloS one</title><description>One of the key questions about genomic alterations in cancer is whether they are functional in the sense of contributing to the selective advantage of tumor cells. The frequency with which an alteration occurs might reflect its ability to increase cancer cell growth, or alternatively, enhanced instability of a locus may increase the frequency with which it is found to be aberrant in tumors, regardless of oncogenic impact. Here we've addressed this on a genome-wide scale for cancer-associated focal deletions, which are known to pinpoint both tumor suppressor genes (tumor suppressors) and unstable loci. Based on DNA copy number analysis of over one-thousand human cancers representing ten different tumor types, we observed five loci with focal deletion frequencies above 5%, including the A2BP1 gene at 16p13.3 and the MACROD2 gene at 20p12.1. However, neither RNA expression nor functional studies support a tumor suppressor role for either gene. Further analyses suggest instead that these are sites of increased genomic instability and that they resemble common fragile sites (CFS). Genome-wide analysis revealed properties of CFS-like recurrent deletions that distinguish them from deletions affecting tumor suppressor genes, including their isolation at specific loci away from other genomic deletion sites, a considerably smaller deletion size, and dispersal throughout the affected locus rather than assembly at a common site of overlap. Additionally, CFS-like deletions have less impact on gene expression and are enriched in cell lines compared to primary tumors. We show that loci affected by CFS-like deletions are often distinct from known common fragile sites. Indeed, we find that each tumor tissue type has its own spectrum of CFS-like deletions, and that colon cancers have many more CFS-like deletions than other tumor types. We present simple rules that can pinpoint focal deletions that are not CFS-like and more likely to affect functional tumor suppressors.</description><subject>Cancer</subject><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqVzE0OgjAQQOHGxET8uYGLLt2ILYUqaxA9AHvSkMGUlA4yJV5fY7yAq7f58hjbSxFLdZanHufJGxeP6CEWQutEpwsWyVwlR50ItWJrol6ITF20jlhZv5CXloL1beCFCfDAyQJx7HiFrXG8BAfBoidu_Qf4FiZ-A48DUMzh-9-yZWccwe7XDTtU17q4H8cJnzNQaAZLLThnPOBMjUxlkok0V7n6g74BLzJEPQ</recordid><startdate>20130601</startdate><enddate>20130601</enddate><creator>Rajaram, Megha</creator><creator>Zhang, Jianping</creator><creator>Wang, Tim</creator><creator>Li, Jinyu</creator><creator>Kuscu, Cem</creator><creator>Qi, Huan</creator><creator>Kato, Mamoru</creator><creator>Grubor, Vladimir</creator><creator>Weil, Robert J</creator><creator>Helland, Aslaug</creator><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20130601</creationdate><title>Two Distinct Categories of Focal Deletions in Cancer Genomes. e66264</title><author>Rajaram, Megha ; Zhang, Jianping ; Wang, Tim ; Li, Jinyu ; Kuscu, Cem ; Qi, Huan ; Kato, Mamoru ; Grubor, Vladimir ; Weil, Robert J ; Helland, Aslaug</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_14125049393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rajaram, Megha</creatorcontrib><creatorcontrib>Zhang, Jianping</creatorcontrib><creatorcontrib>Wang, Tim</creatorcontrib><creatorcontrib>Li, Jinyu</creatorcontrib><creatorcontrib>Kuscu, Cem</creatorcontrib><creatorcontrib>Qi, Huan</creatorcontrib><creatorcontrib>Kato, Mamoru</creatorcontrib><creatorcontrib>Grubor, Vladimir</creatorcontrib><creatorcontrib>Weil, Robert J</creatorcontrib><creatorcontrib>Helland, Aslaug</creatorcontrib><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rajaram, Megha</au><au>Zhang, Jianping</au><au>Wang, Tim</au><au>Li, Jinyu</au><au>Kuscu, Cem</au><au>Qi, Huan</au><au>Kato, Mamoru</au><au>Grubor, Vladimir</au><au>Weil, Robert J</au><au>Helland, Aslaug</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Two Distinct Categories of Focal Deletions in Cancer Genomes. e66264</atitle><jtitle>PloS one</jtitle><date>2013-06-01</date><risdate>2013</risdate><volume>8</volume><issue>6</issue><eissn>1932-6203</eissn><abstract>One of the key questions about genomic alterations in cancer is whether they are functional in the sense of contributing to the selective advantage of tumor cells. The frequency with which an alteration occurs might reflect its ability to increase cancer cell growth, or alternatively, enhanced instability of a locus may increase the frequency with which it is found to be aberrant in tumors, regardless of oncogenic impact. Here we've addressed this on a genome-wide scale for cancer-associated focal deletions, which are known to pinpoint both tumor suppressor genes (tumor suppressors) and unstable loci. Based on DNA copy number analysis of over one-thousand human cancers representing ten different tumor types, we observed five loci with focal deletion frequencies above 5%, including the A2BP1 gene at 16p13.3 and the MACROD2 gene at 20p12.1. However, neither RNA expression nor functional studies support a tumor suppressor role for either gene. Further analyses suggest instead that these are sites of increased genomic instability and that they resemble common fragile sites (CFS). Genome-wide analysis revealed properties of CFS-like recurrent deletions that distinguish them from deletions affecting tumor suppressor genes, including their isolation at specific loci away from other genomic deletion sites, a considerably smaller deletion size, and dispersal throughout the affected locus rather than assembly at a common site of overlap. Additionally, CFS-like deletions have less impact on gene expression and are enriched in cell lines compared to primary tumors. We show that loci affected by CFS-like deletions are often distinct from known common fragile sites. Indeed, we find that each tumor tissue type has its own spectrum of CFS-like deletions, and that colon cancers have many more CFS-like deletions than other tumor types. We present simple rules that can pinpoint focal deletions that are not CFS-like and more likely to affect functional tumor suppressors.</abstract><doi>10.1371/journal.pone.0066264</doi></addata></record>
fulltext fulltext
identifier EISSN: 1932-6203
ispartof PloS one, 2013-06, Vol.8 (6)
issn 1932-6203
language eng
recordid cdi_proquest_miscellaneous_1412504939
source Public Library of Science (PLoS) Journals Open Access; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Cancer
title Two Distinct Categories of Focal Deletions in Cancer Genomes. e66264
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T17%3A01%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Two%20Distinct%20Categories%20of%20Focal%20Deletions%20in%20Cancer%20Genomes.%20e66264&rft.jtitle=PloS%20one&rft.au=Rajaram,%20Megha&rft.date=2013-06-01&rft.volume=8&rft.issue=6&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0066264&rft_dat=%3Cproquest%3E1412504939%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1412504939&rft_id=info:pmid/&rfr_iscdi=true